Industry Research Reports
Part 1
Part 2
Part 3
Part 5
Home > Reports >
Medical Devices & Consumables
>
Global Neuroscience Antibody Market Research Report 2023
Global Neuroscience Antibody Market Research Report 2023
-
Description
- Table of Contents
- Table of Figures
- PDF Download
-
Description
- Table of Contents
- Table of Figures
- PDF Download
Neuroscience Antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. The key to neuroscience research is the identification of cellular, molecular and tissue features that can be used as biomarkers to help identify patients at risk for neurological disease and as targets for new therapies. According to QYResearch’s new survey, global Neuroscience Antibody market is projected to reach US$ 5633.8 million in 2029, increasing from US$ 3370 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029.
The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuroscience Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc
Santa Cruz Biotechnology Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience
Segment by Type
Antibodies
Research Reagents
Segment by Application
Hospitals and Diagnostics Centers
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neuroscience Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source 1 Neuroscience Antibody Market Overview
1.1 Product Overview and Scope of Neuroscience Antibody
1.2 Neuroscience Antibody Segment by Type
1.2.1 Global Neuroscience Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Antibodies
1.2.3 Research Reagents
1.3 Neuroscience Antibody Segment by Application
1.3.1 Global Neuroscience Antibody Market Value by Application: (2023-2029)
1.3.2 Hospitals and Diagnostics Centers
1.3.3 Academic and Research Institutes
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Global Neuroscience Antibody Market Size Estimates and Forecasts
1.4.1 Global Neuroscience Antibody Revenue 2018-2029
1.4.2 Global Neuroscience Antibody Sales 2018-2029
1.4.3 Global Neuroscience Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2.1 Global Neuroscience Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global Neuroscience Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Neuroscience Antibody Average Price by Manufacturers (2018-2023)
2.4 Global Neuroscience Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Neuroscience Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuroscience Antibody, Product Type & Application
2.7 Neuroscience Antibody Market Competitive Situation and Trends
2.7.1 Neuroscience Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neuroscience Antibody Players Market Share by Revenue
2.7.3 Global Neuroscience Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3.1 Global Neuroscience Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neuroscience Antibody Global Neuroscience Antibody Sales by Region: 2018-2029
3.2.1 Global Neuroscience Antibody Sales by Region: 2018-2023
3.2.2 Global Neuroscience Antibody Sales by Region: 2024-2029
3.3 Global Neuroscience Antibody Global Neuroscience Antibody Revenue by Region: 2018-2029
3.3.1 Global Neuroscience Antibody Revenue by Region: 2018-2023
3.3.2 Global Neuroscience Antibody Revenue by Region: 2024-2029
3.4 North America Neuroscience Antibody Market Facts & Figures by Country
3.4.1 North America Neuroscience Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neuroscience Antibody Sales by Country (2018-2029)
3.4.3 North America Neuroscience Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neuroscience Antibody Market Facts & Figures by Country
3.5.1 Europe Neuroscience Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neuroscience Antibody Sales by Country (2018-2029)
3.5.3 Europe Neuroscience Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuroscience Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Neuroscience Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neuroscience Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific Neuroscience Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neuroscience Antibody Market Facts & Figures by Country
3.7.1 Latin America Neuroscience Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neuroscience Antibody Sales by Country (2018-2029)
3.7.3 Latin America Neuroscience Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuroscience Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuroscience Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neuroscience Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neuroscience Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4.1 Global Neuroscience Antibody Sales by Type (2018-2029)
4.1.1 Global Neuroscience Antibody Sales by Type (2018-2023)
4.1.2 Global Neuroscience Antibody Sales by Type (2024-2029)
4.1.3 Global Neuroscience Antibody Sales Market Share by Type (2018-2029)
4.2 Global Neuroscience Antibody Revenue by Type (2018-2029)
4.2.1 Global Neuroscience Antibody Revenue by Type (2018-2023)
4.2.2 Global Neuroscience Antibody Revenue by Type (2024-2029)
4.2.3 Global Neuroscience Antibody Revenue Market Share by Type (2018-2029)
4.3 Global Neuroscience Antibody Price by Type (2018-2029)
5.1 Global Neuroscience Antibody Sales by Application (2018-2029)
5.1.1 Global Neuroscience Antibody Sales by Application (2018-2023)
5.1.2 Global Neuroscience Antibody Sales by Application (2024-2029)
5.1.3 Global Neuroscience Antibody Sales Market Share by Application (2018-2029)
5.2 Global Neuroscience Antibody Revenue by Application (2018-2029)
5.2.1 Global Neuroscience Antibody Revenue by Application (2018-2023)
5.2.2 Global Neuroscience Antibody Revenue by Application (2024-2029)
5.2.3 Global Neuroscience Antibody Revenue Market Share by Application (2018-2029)
5.3 Global Neuroscience Antibody Price by Application (2018-2029)
6.1 Abcam
6.1.1 Abcam Corporation Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abcam Neuroscience Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 BioLegend
6.2.1 BioLegend Corporation Information
6.2.2 BioLegend Description and Business Overview
6.2.3 BioLegend Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BioLegend Neuroscience Antibody Product Portfolio
6.2.5 BioLegend Recent Developments/Updates
6.3 Bio-Rad Laboratories Inc
6.3.1 Bio-Rad Laboratories Inc Corporation Information
6.3.2 Bio-Rad Laboratories Inc Description and Business Overview
6.3.3 Bio-Rad Laboratories Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bio-Rad Laboratories Inc Neuroscience Antibody Product Portfolio
6.3.5 Bio-Rad Laboratories Inc Recent Developments/Updates
6.4 Cell Signaling Technology
6.4.1 Cell Signaling Technology Corporation Information
6.4.2 Cell Signaling Technology Description and Business Overview
6.4.3 Cell Signaling Technology Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cell Signaling Technology Neuroscience Antibody Product Portfolio
6.4.5 Cell Signaling Technology Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Roche Neuroscience Antibody Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Genscript Biotech Corp
6.6.1 Genscript Biotech Corp Corporation Information
6.6.2 Genscript Biotech Corp Description and Business Overview
6.6.3 Genscript Biotech Corp Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Genscript Biotech Corp Neuroscience Antibody Product Portfolio
6.6.5 Genscript Biotech Corp Recent Developments/Updates
6.7 Merck KGaA
6.6.1 Merck KGaA Corporation Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck KGaA Neuroscience Antibody Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Rockland Immunochemicals Inc
6.8.1 Rockland Immunochemicals Inc Corporation Information
6.8.2 Rockland Immunochemicals Inc Description and Business Overview
6.8.3 Rockland Immunochemicals Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Rockland Immunochemicals Inc Neuroscience Antibody Product Portfolio
6.8.5 Rockland Immunochemicals Inc Recent Developments/Updates
6.9 Santa Cruz Biotechnology Inc
6.9.1 Santa Cruz Biotechnology Inc Corporation Information
6.9.2 Santa Cruz Biotechnology Inc Description and Business Overview
6.9.3 Santa Cruz Biotechnology Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Santa Cruz Biotechnology Inc Neuroscience Antibody Product Portfolio
6.9.5 Santa Cruz Biotechnology Inc Recent Developments/Updates
6.10 Siemens Healthineers
6.10.1 Siemens Healthineers Corporation Information
6.10.2 Siemens Healthineers Description and Business Overview
6.10.3 Siemens Healthineers Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Siemens Healthineers Neuroscience Antibody Product Portfolio
6.10.5 Siemens Healthineers Recent Developments/Updates
6.11 Tecan Group Ltd
6.11.1 Tecan Group Ltd Corporation Information
6.11.2 Tecan Group Ltd Neuroscience Antibody Description and Business Overview
6.11.3 Tecan Group Ltd Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Tecan Group Ltd Neuroscience Antibody Product Portfolio
6.11.5 Tecan Group Ltd Recent Developments/Updates
6.12 Thermo Fisher Scientific Inc
6.12.1 Thermo Fisher Scientific Inc Corporation Information
6.12.2 Thermo Fisher Scientific Inc Neuroscience Antibody Description and Business Overview
6.12.3 Thermo Fisher Scientific Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Thermo Fisher Scientific Inc Neuroscience Antibody Product Portfolio
6.12.5 Thermo Fisher Scientific Inc Recent Developments/Updates
6.13 Enzo Life Sciences AG
6.13.1 Enzo Life Sciences AG Corporation Information
6.13.2 Enzo Life Sciences AG Neuroscience Antibody Description and Business Overview
6.13.3 Enzo Life Sciences AG Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Enzo Life Sciences AG Neuroscience Antibody Product Portfolio
6.13.5 Enzo Life Sciences AG Recent Developments/Updates
6.14 Neobioscience
6.14.1 Neobioscience Corporation Information
6.14.2 Neobioscience Neuroscience Antibody Description and Business Overview
6.14.3 Neobioscience Neuroscience Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Neobioscience Neuroscience Antibody Product Portfolio
6.14.5 Neobioscience Recent Developments/Updates
7.1 Neuroscience Antibody Industry Chain Analysis
7.2 Neuroscience Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuroscience Antibody Production Mode & Process
7.4 Neuroscience Antibody Sales and Marketing
7.4.1 Neuroscience Antibody Sales Channels
7.4.2 Neuroscience Antibody Distributors
7.5 Neuroscience Antibody Customers
8.1 Neuroscience Antibody Industry Trends
8.2 Neuroscience Antibody Market Drivers
8.3 Neuroscience Antibody Market Challenges
8.4 Neuroscience Antibody Market Restraints
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
List of Tables
Table 1. Global Neuroscience Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Neuroscience Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Neuroscience Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global Neuroscience Antibody Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Neuroscience Antibody Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Neuroscience Antibody Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Neuroscience Antibody Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Neuroscience Antibody Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Neuroscience Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Neuroscience Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neuroscience Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Neuroscience Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neuroscience Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuroscience Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Neuroscience Antibody Sales by Region (2018-2023) & (K Units)
Table 18. Global Neuroscience Antibody Sales Market Share by Region (2018-2023)
Table 19. Global Neuroscience Antibody Sales by Region (2024-2029) & (K Units)
Table 20. Global Neuroscience Antibody Sales Market Share by Region (2024-2029)
Table 21. Global Neuroscience Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Neuroscience Antibody Revenue Market Share by Region (2018-2023)
Table 23. Global Neuroscience Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Neuroscience Antibody Revenue Market Share by Region (2024-2029)
Table 25. North America Neuroscience Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Neuroscience Antibody Sales by Country (2018-2023) & (K Units)
Table 27. North America Neuroscience Antibody Sales by Country (2024-2029) & (K Units)
Table 28. North America Neuroscience Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Neuroscience Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Neuroscience Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Neuroscience Antibody Sales by Country (2018-2023) & (K Units)
Table 32. Europe Neuroscience Antibody Sales by Country (2024-2029) & (K Units)
Table 33. Europe Neuroscience Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Neuroscience Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Neuroscience Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Neuroscience Antibody Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Neuroscience Antibody Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Neuroscience Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Neuroscience Antibody Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neuroscience Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Neuroscience Antibody Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Neuroscience Antibody Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Neuroscience Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Neuroscience Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Neuroscience Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Neuroscience Antibody Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Neuroscience Antibody Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Neuroscience Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Neuroscience Antibody Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Neuroscience Antibody Sales (K Units) by Type (2018-2023)
Table 51. Global Neuroscience Antibody Sales (K Units) by Type (2024-2029)
Table 52. Global Neuroscience Antibody Sales Market Share by Type (2018-2023)
Table 53. Global Neuroscience Antibody Sales Market Share by Type (2024-2029)
Table 54. Global Neuroscience Antibody Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Neuroscience Antibody Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Neuroscience Antibody Revenue Market Share by Type (2018-2023)
Table 57. Global Neuroscience Antibody Revenue Market Share by Type (2024-2029)
Table 58. Global Neuroscience Antibody Price (US$/Unit) by Type (2018-2023)
Table 59. Global Neuroscience Antibody Price (US$/Unit) by Type (2024-2029)
Table 60. Global Neuroscience Antibody Sales (K Units) by Application (2018-2023)
Table 61. Global Neuroscience Antibody Sales (K Units) by Application (2024-2029)
Table 62. Global Neuroscience Antibody Sales Market Share by Application (2018-2023)
Table 63. Global Neuroscience Antibody Sales Market Share by Application (2024-2029)
Table 64. Global Neuroscience Antibody Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Neuroscience Antibody Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Neuroscience Antibody Revenue Market Share by Application (2018-2023)
Table 67. Global Neuroscience Antibody Revenue Market Share by Application (2024-2029)
Table 68. Global Neuroscience Antibody Price (US$/Unit) by Application (2018-2023)
Table 69. Global Neuroscience Antibody Price (US$/Unit) by Application (2024-2029)
Table 70. Abcam Corporation Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Abcam Neuroscience Antibody Product
Table 74. Abcam Recent Developments/Updates
Table 75. BioLegend Corporation Information
Table 76. BioLegend Description and Business Overview
Table 77. BioLegend Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. BioLegend Neuroscience Antibody Product
Table 79. BioLegend Recent Developments/Updates
Table 80. Bio-Rad Laboratories Inc Corporation Information
Table 81. Bio-Rad Laboratories Inc Description and Business Overview
Table 82. Bio-Rad Laboratories Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bio-Rad Laboratories Inc Neuroscience Antibody Product
Table 84. Bio-Rad Laboratories Inc Recent Developments/Updates
Table 85. Cell Signaling Technology Corporation Information
Table 86. Cell Signaling Technology Description and Business Overview
Table 87. Cell Signaling Technology Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Cell Signaling Technology Neuroscience Antibody Product
Table 89. Cell Signaling Technology Recent Developments/Updates
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Roche Neuroscience Antibody Product
Table 94. Roche Recent Developments/Updates
Table 95. Genscript Biotech Corp Corporation Information
Table 96. Genscript Biotech Corp Description and Business Overview
Table 97. Genscript Biotech Corp Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Genscript Biotech Corp Neuroscience Antibody Product
Table 99. Genscript Biotech Corp Recent Developments/Updates
Table 100. Merck KGaA Corporation Information
Table 101. Merck KGaA Description and Business Overview
Table 102. Merck KGaA Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merck KGaA Neuroscience Antibody Product
Table 104. Merck KGaA Recent Developments/Updates
Table 105. Rockland Immunochemicals Inc Corporation Information
Table 106. Rockland Immunochemicals Inc Description and Business Overview
Table 107. Rockland Immunochemicals Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Rockland Immunochemicals Inc Neuroscience Antibody Product
Table 109. Rockland Immunochemicals Inc Recent Developments/Updates
Table 110. Santa Cruz Biotechnology Inc Corporation Information
Table 111. Santa Cruz Biotechnology Inc Description and Business Overview
Table 112. Santa Cruz Biotechnology Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Santa Cruz Biotechnology Inc Neuroscience Antibody Product
Table 114. Santa Cruz Biotechnology Inc Recent Developments/Updates
Table 115. Siemens Healthineers Corporation Information
Table 116. Siemens Healthineers Description and Business Overview
Table 117. Siemens Healthineers Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Siemens Healthineers Neuroscience Antibody Product
Table 119. Siemens Healthineers Recent Developments/Updates
Table 120. Tecan Group Ltd Corporation Information
Table 121. Tecan Group Ltd Description and Business Overview
Table 122. Tecan Group Ltd Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Tecan Group Ltd Neuroscience Antibody Product
Table 124. Tecan Group Ltd Recent Developments/Updates
Table 125. Thermo Fisher Scientific Inc Corporation Information
Table 126. Thermo Fisher Scientific Inc Description and Business Overview
Table 127. Thermo Fisher Scientific Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Thermo Fisher Scientific Inc Neuroscience Antibody Product
Table 129. Thermo Fisher Scientific Inc Recent Developments/Updates
Table 130. Enzo Life Sciences AG Corporation Information
Table 131. Enzo Life Sciences AG Description and Business Overview
Table 132. Enzo Life Sciences AG Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Enzo Life Sciences AG Neuroscience Antibody Product
Table 134. Enzo Life Sciences AG Recent Developments/Updates
Table 135. Neobioscience Corporation Information
Table 136. Neobioscience Description and Business Overview
Table 137. Neobioscience Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Neobioscience Neuroscience Antibody Product
Table 139. Neobioscience Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Neuroscience Antibody Distributors List
Table 143. Neuroscience Antibody Customers List
Table 144. Neuroscience Antibody Market Trends
Table 145. Neuroscience Antibody Market Drivers
Table 146. Neuroscience Antibody Market Challenges
Table 147. Neuroscience Antibody Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuroscience Antibody
Figure 2. Global Neuroscience Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Neuroscience Antibody Market Share by Type in 2022 & 2029
Figure 4. Antibodies Product Picture
Figure 5. Research Reagents Product Picture
Figure 6. Global Neuroscience Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Neuroscience Antibody Market Share by Application in 2022 & 2029
Figure 8. Hospitals and Diagnostics Centers
Figure 9. Academic and Research Institutes
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Global Neuroscience Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Neuroscience Antibody Market Size (2018-2029) & (US$ Million)
Figure 13. Global Neuroscience Antibody Sales (2018-2029) & (K Units)
Figure 14. Global Neuroscience Antibody Average Price (US$/Unit) & (2018-2029)
Figure 15. Neuroscience Antibody Report Years Considered
Figure 16. Neuroscience Antibody Sales Share by Manufacturers in 2022
Figure 17. Global Neuroscience Antibody Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Neuroscience Antibody Players: Market Share by Revenue in 2022
Figure 19. Neuroscience Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Neuroscience Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Neuroscience Antibody Sales Market Share by Country (2018-2029)
Figure 22. North America Neuroscience Antibody Revenue Market Share by Country (2018-2029)
Figure 23. United States Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Neuroscience Antibody Sales Market Share by Country (2018-2029)
Figure 26. Europe Neuroscience Antibody Revenue Market Share by Country (2018-2029)
Figure 27. Germany Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Neuroscience Antibody Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Neuroscience Antibody Revenue Market Share by Region (2018-2029)
Figure 34. China Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Neuroscience Antibody Sales Market Share by Country (2018-2029)
Figure 42. Latin America Neuroscience Antibody Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Neuroscience Antibody Sales Market Share by Country (2018-2029)
Figure 47. Middle East & Africa Neuroscience Antibody Revenue Market Share by Country (2018-2029)
Figure 48. Turkey Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. UAE Neuroscience Antibody Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Global Sales Market Share of Neuroscience Antibody by Type (2018-2029)
Figure 52. Global Revenue Market Share of Neuroscience Antibody by Type (2018-2029)
Figure 53. Global Neuroscience Antibody Price (US$/Unit) by Type (2018-2029)
Figure 54. Global Sales Market Share of Neuroscience Antibody by Application (2018-2029)
Figure 55. Global Revenue Market Share of Neuroscience Antibody by Application (2018-2029)
Figure 56. Global Neuroscience Antibody Price (US$/Unit) by Application (2018-2029)
Figure 57. Neuroscience Antibody Value Chain
Figure 58. Neuroscience Antibody Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed Neuroscience Antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. The key to neuroscience research is the identification of cellular, molecular and tissue features that can be used as biomarkers to help identify patients at risk for neurological disease and as targets for new therapies. According to QYResearch’s new survey, global Neuroscience Antibody market is projected to reach US$ 5633.8 million in 2029, increasing from US$ 3370 million in 2022, with the CAGR of 7.7% during the period of 2023 to 2029.
The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuroscience Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc
Santa Cruz Biotechnology Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience
Segment by Type
Antibodies
Research Reagents
Segment by Application
Hospitals and Diagnostics Centers
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neuroscience Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
-
Fastest report delivery service
-
More than 17 years of vast experience
-
Operation for 24 * 7 & 365 days
-
In-depth and comprehensive analysis
-
Professional and timely after-sales service
-
Owns large database
Add to Cart
Buy Now